Hyperplastic polyps arising in autoimmune metaplastic atrophic gastritis patients: is this a distinct clinicopathological entity?

References

• Carmack SW, Genta RM, Schuler CM, et al. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104:1524–1532.
   PubMed Web of Science ®Google Scholar
• Dijkhuizen SM, Entius MM, Clement MJ, et al. Multiple hyperplastic polyps in the stomach: evidence for clonality and neoplastic potential. Gastroenterology. 1997;112:561–566.
   PubMed Web of Science ®Google Scholar
• Terada T. Malignant transformation of foveolar hyperplastic polyp of the stomach: a histopathological study. Med Oncol. 2011;28:941–944.
   PubMed Web of Science ®Google Scholar
• Yao T, Kajiwara M, Kuroiwa S, et al. Malignant transformation of gastric hyperplastic polyps: alteration of phenotypes, proliferative activity, and p53 expression. Hum Pathol. 2002;33:1016–1022.
   PubMed Web of Science ®Google Scholar
• Imura J, Hayashi S, Ichikawa K, et al. Malignant transformation of hyperplastic gastric polyps: an immunohistochemical and pathological study of the changes of neoplastic phenotype. Oncol Lett. 2014;7:1459–1463.
   PubMed Web of Science ®Google Scholar
• Daibo M, Itabashi M, Hirota T. Malignant transformation of gastric hyperplastic polyps. Am J Gastroenterol. 1987;82:1016–1025.
   PubMed Web of Science ®Google Scholar
• Orlowska J, Jarosz D, Pachlewski J, et al. Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol. 1995;90:2152–2159.
   PubMed Web of Science ®Google Scholar
• Abraham SC, Singh VK, Yardley JH, et al. Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol. 2001;25:500–507.
   PubMed Web of Science ®Google Scholar
• Han AR, Sung CO, Kim KM, et al. The clinicopathological features of gastric hyperplastic polyps with neoplastic transformations: a suggestion of indication for endoscopic polypectomy. Gut Liver. 2009;3:271–275.
   PubMed Web of Science ®Google Scholar
• Kang HM, Oh TH, Seo JY, et al. Clinical factors predicting for neoplastic transformation of gastric hyperplastic polyps. Korean J Gastroenterol. 2011;58:184–189.
   PubMedGoogle Scholar
• Ahn JY, Son DH, Choi KD, et al. Neoplasms arising in large gastric hyperplastic polyps: endoscopic and pathologic features. Gastrointest Endosc. 2014;80:1005–1013.e2.
   PubMed Web of Science ®Google Scholar
• Vatansever S, Akpınar Z, Alper E, et al. Gastric polyps and polypoid lesions: retrospective analysis of 36650 endoscopic procedures in 29940 patients. Turk J Gastroenterol. 2015;26:117–122.
   PubMed Web of Science ®Google Scholar
• Horvath B, Pai RK. Prevalence of Helicobacter pylori in gastric hyperplastic polyps. Int J Surg Pathol. 2016;24:704–708.
   PubMed Web of Science ®Google Scholar
• Miceli E, Lenti MV, Padula D, et al. Common features of patients with autoimmune atrophic gastritis. Clin Gastroenterol Hepatol. 2012;10:812–814.
   PubMed Web of Science ®Google Scholar
• Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996;156:1097–1100.
   PubMedGoogle Scholar
• Park JY, Cornish TC, Lam-Himlin D, et al. Gastric lesions in patients with autoimmune metaplastic atrophic gastritis (AMAG) in a tertiary care setting. Am J Surg Pathol. 2010;34:1591–1598.
   PubMed Web of Science ®Google Scholar
• Zhang H, Jin Z, Cui R, et al. Autoimmune metaplastic atrophic gastritis in Chinese: a study of 320 patients at a large tertiary medical center. Scand J Gastroenterol. 2017;52:150–156.
   PubMed Web of Science ®Google Scholar
• Murphy G, Dawsey SM, Engels EA, et al. Cancer risk after pernicious anemia in the US elderly population. Clin Gastroenterol Hepatol. 2015;13:2282–2289.
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Miyatani H, Yoshida Y, et al. Malignant transformation of a gastric hyperplastic polyp in a context of Helicobacter pylori-negative autoimmune gastritis: a case report. BMC Gastroenterol. 2016;16:130–136.
   PubMed Web of Science ®Google Scholar
• Yamada T, Ichikawa H. X-ray diagnosis of elevated lesions of the stomach. Radiology. 1974;110:79–83.
   PubMed Web of Science ®Google Scholar
• Vanoli A, La Rosa S, Luinetti O, et al. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions. Hum Pathol. 2013;44:1827–1837.
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–112.
   PubMed Web of Science ®Google Scholar
• Haruma K, Yoshihara M, Sumii K, et al. Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid-type early gastric carcinoma. Scand J Gastroenterol. 1993;28:633–637.
   PubMed Web of Science ®Google Scholar
• Soykan I, Yakut M, Keskin O, et al. Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis. Digestion. 2012;86:20–26.
   PubMed Web of Science ®Google Scholar
• Genta RM. Inflammatory disorders of the stomach. In: Odze RD, Goldblum JR, Crawford JM, editors. Surgical pathology of the GI tract, liver, biliary tract, and pancreas, 1st ed. Philadelphia (PA): Saunders Press; 2004. p. 143–176.
   Google Scholar
• Stolte M, Sticht T, Eidt S, et al. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy. 1994;26:659–665.
   PubMed Web of Science ®Google Scholar
• Schmitz JM, Stolte M. Gastric polyps as precancerous lesions. Gastrointest Endosc Clin N Am. 1997;7:29–46.
   PubMedGoogle Scholar
• Lauwers GY, Franceschi S, Carneiro F, et al. Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, et al. editors. WHO classification of tumours of the digestive system (IARC WHO classification of tumours), 4th ed. Lyon (France): IARC Press; 2010. p. 48–58.
   Google Scholar
• Anjiki H, Mukaisho KI, Kadomoto Y, et al. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy. Clin J Gastroenterol. 2017;10:128–136.
   PubMed Web of Science ®Google Scholar
• Saravanan R, Kamalaporn P, Streutker C, et al. Gastric polyp in pernicious anemia: an argument to remove even when biopsy shows hyperplasia. Endoscopy. 2008;40:E77–E78.
   PubMed Web of Science ®Google Scholar
• Fossmark R, Martinsen TC, Bakkelund KE, et al. Hypergastrinaemia induced by partial corpectomy results in development of enterochromaffin-like cell carcinoma in male Japanese cotton rats. Scand J Gastroenterol. 2004;39:919–926.
   PubMed Web of Science ®Google Scholar
• Fossmark R, Sagatun L, Nordrum IS, et al. Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival. Apmis. 2015;123:509–514.
   PubMed Web of Science ®Google Scholar
• Hongo M, Fujimoto K; Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol. 2010;45:618–624.
   PubMed Web of Science ®Google Scholar
• Bakke I, Qvigstad G, Sandvik AK, et al. The CCK-2 receptor is located on the ECL cell, but not on the parietal cell. Scand J Gastroenterol. 2001;36:1128–1133.
   PubMed Web of Science ®Google Scholar
• Rindi G, Solcia E. Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors. Gastroenterol Clin North Am. 2007;36:851–865.
   PubMed Web of Science ®Google Scholar
• Toh BH. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev. 2014;13:459–462.
   PubMed Web of Science ®Google Scholar